Search

Memorial Sloan Kettering Cancer Center (MSK) has joined the COVID-19 Technology Access Framework, a multi-site effort aimed at accelerating the production of essential health-related technologies that will help prevent, diagnose, and treat infections during the COVID-19 pandemic.

… Wednesday, April 29, 2020 Memorial Sloan Kettering Cancer Center (MSK) has joined the COVID-19 Technology Access Framework , a multi-site effort aimed at accelerating the production of essential health-related technologies that will help prevent, diagnose, and treat infections during the COVID-19 pandemic

Incorporating radiomics with methyl guanine methyl transferase (MGMT) status can more accurately stratify glioblastoma patients into groups with different survival risks compared to using either prediction tool in isolation.

… Thursday, April 4, 2019 Incorporating radiomics with methyl guanine methyl transferase ( MGMT) status can more accurately stratify glioblastoma patients into groups with different survival risks compared to using either prediction tool in isolation, according to the results of our retrospective research

An innovative 3D motion management platform for guiding stereotactic body radiation therapy (SBRT) significantly reduced late urinary toxicity in patients treated for prostate cancer compared to a commercial image-guidance system, according to study results presented October 2 at the ASTRO 2023 Annual Meeting in San Diego.

… Wednesday, October 11, 2023 An innovative 3D motion management platform for guiding stereotactic body radiation therapy (SBRT) significantly reduced late urinary toxicity in patients treated for prostate cancer compared to a commercial image-guidance system, according to  study results presented October

Learn how a new kind of CAR T cell therapy could be a major advance for treating acute myeloid leukemia.

… Monday, April 22, 2024 Acute myeloid leukemia (AML) is one of the most challenging blood cancers . The disease moves quickly and needs aggressive treatment with chemotherapy , sometimes followed by a  bone marrow transplant . Even when the first round of therapy works, AML often returns. Now a clinical

Memorial Sloan Kettering Cancer Center (MSK) was recently notified by a third-party software vendor, Accellion, Inc., of a technical vulnerability in a document-sharing system used at MSK. MSK was one of many Accellion customers whose document-sharing systems were involved in this incident. After a full investigation, we discovered that an unauthorized party was able to access and copy a subset of electronic documents stored on the system.

… Wednesday, March 31, 2021 Memorial Sloan Kettering Cancer Center (MSK) was recently notified by a third-party software vendor, Accellion, Inc., of a technical vulnerability in a document-sharing system used at MSK. MSK was one of many Accellion customers whose document-sharing systems were involved in

In recent years, there has been a shift toward capturing information about the side effects caused by new treatments directly from patients.

… Tuesday, February 26, 2019 Summary Patients’ reports on their symptoms and experiences are considered the gold standard for documenting side effects in clinical research. Memorial Sloan Kettering researchers oversee hundreds of clinical trials every year. Some of the most exciting and potentially revolutionary

Join us from 10:00 a.m. to 12:00 p.m. ET for the June 11 session of “MSK Science Spotlight” recognizing this year’s winners of the Tri-Institutional Breakout Prize for Junior Investigators.

… Thursday, June 11, 2020 Join us from 10:00 a.m. to 12:00 p.m. ET for the June 11 session of “ MSK Science Spotlight ” recognizing this year’s winners of the Tri-Institutional Breakout Prize for Junior Investigators – Manu Setty , PhD of the Dana Pe’er Lab at the Sloan Kettering Institute ; Alexander

Two Memorial Sloan Kettering physician-scientists were elected to one of the nation’s oldest and most respected medical honor societies.

… Friday, July 11, 2014 Physician-scientists Viviane Tabar and Lorenz Studer have been elected to the American Society for Clinical Investigation (ASCI) for 2014. The ASCI, one of the nation’s oldest and most respected medical honor societies, is dedicated to the advancement of research that extends our

For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.

… Wednesday, November 25, 2020 Summary For nearly two decades, MSK has led the way in matching people who have lung cancer with the best targeted therapies for their disease. EGFR . ALK . BRAF. MET. NTRK. RET. ROS1. This may seem like what you see when you dump a box of Scrabble tiles on a table, but these

Para que el tratamiento personalizado funcione, es importante analizar el tumor de cada persona en busca de mutaciones genéticas y encontrar los mejores fármacos para atacar esas mutaciones.

… Wednesday, November 25, 2020 Resumen Durante casi dos décadas, MSK ha sido pionero en conectar a las personas con cáncer pulmonar con las mejores terapias dirigidas para su enfermedad. EGFR . ALK . BRAF. MET. NTRK. RET. ROS1. Esto puede parecerse a lo que ve cuando derrama una caja de fichas de Scrabble